44 related articles for article (PubMed ID: 8570730)
1. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
Peng Q; Warloe T; Moan J; Heyerdahl H; Steen HB; Nesland JM; Giercksky KE
Photochem Photobiol; 1995 Nov; 62(5):906-13. PubMed ID: 8570730
[TBL] [Abstract][Full Text] [Related]
2. An intriguing case of cutaneous noduloulcerative lesion in the vicinity of genitalia.
Potula A; Nayak MD; Hegde P; Jaiswal D; Rao R
Indian J Sex Transm Dis AIDS; 2023; 44(1):100-101. PubMed ID: 37457528
[No Abstract] [Full Text] [Related]
3. 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.
Howley R; Chandratre S; Chen B
Bioengineering (Basel); 2023 Apr; 10(4):. PubMed ID: 37106683
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide (DMSO): a solvent that may solve selected cutaneous clinical challenges.
Karim M; Boikess RS; Schwartz RA; Cohen PJ
Arch Dermatol Res; 2023 Aug; 315(6):1465-1472. PubMed ID: 36459193
[TBL] [Abstract][Full Text] [Related]
5. Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma.
Jones PS; Yekula A; Lansbury E; Small JL; Ayinon C; Mordecai S; Hochberg FH; Tigges J; Delcuze B; Charest A; Ghiran I; Balaj L; Carter BS
EBioMedicine; 2019 Oct; 48():23-35. PubMed ID: 31628025
[TBL] [Abstract][Full Text] [Related]
6. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
[TBL] [Abstract][Full Text] [Related]
7. Beyond the margins: real-time detection of cancer using targeted fluorophores.
Zhang RR; Schroeder AB; Grudzinski JJ; Rosenthal EL; Warram JM; Pinchuk AN; Eliceiri KW; Kuo JS; Weichert JP
Nat Rev Clin Oncol; 2017 Jun; 14(6):347-364. PubMed ID: 28094261
[TBL] [Abstract][Full Text] [Related]
8. Combination of Sonodynamic and Photodynamic Therapy against Cancer Would Be Effective through Using a Regulated Size of Nanoparticles.
Miyoshi N; Kundu SK; Tuziuti T; Yasui K; Shimada I; Ito Y
Nanosci Nanoeng; 2016 Feb; 4(1):1-11. PubMed ID: 27088115
[TBL] [Abstract][Full Text] [Related]
9. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
10. Derivatives of 5-aminolevulinic Acid for photodynamic therapy.
Donnelly RF; McCarron PA; Woolfson AD
Perspect Medicin Chem; 2007 Dec; 1():49-63. PubMed ID: 19812736
[TBL] [Abstract][Full Text] [Related]
11. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
Pierre MB; Ricci E; Tedesco AC; Bentley MV
Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.
Perotti C; Fukuda H; DiVenosa G; MacRobert AJ; Batlle A; Casas A
Br J Cancer; 2004 Apr; 90(8):1660-5. PubMed ID: 15083200
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients.
Schleier P; Hyckel P; Berndt A; Bode HP; Albrecht V; Hindermann W; Kosmehl H; Zenk W; Schumann D
J Cancer Res Clin Oncol; 2004 May; 130(5):279-84. PubMed ID: 14997383
[TBL] [Abstract][Full Text] [Related]
14. Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.
Otake M; Nishiwaki M; Kobayashi Y; Baba S; Kohno E; Kawasaki T; Fujise Y; Nakamura H
Br J Cancer; 2003 Aug; 89(4):730-6. PubMed ID: 12915887
[TBL] [Abstract][Full Text] [Related]
15. Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.
Perotti C; Casas A; Fukuda H; Sacca P; Batlle A
Br J Cancer; 2003 Feb; 88(3):432-7. PubMed ID: 12569388
[TBL] [Abstract][Full Text] [Related]
16. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo.
Tunstall RG; Barnett AA; Schofield J; Griffiths J; Vernon DI; Brown SB; Roberts DJ
Br J Cancer; 2002 Jul; 87(2):246-50. PubMed ID: 12107850
[TBL] [Abstract][Full Text] [Related]
17. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization.
Casas A; Perotti C; Fukuda H; Rogers L; Butler AR; Batlle A
Br J Cancer; 2001 Nov; 85(11):1794-800. PubMed ID: 11742504
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.
De Rosa FS; Bentley MV
Pharm Res; 2000 Dec; 17(12):1447-55. PubMed ID: 11303952
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy: a review.
McCaughan JS
Drugs Aging; 1999 Jul; 15(1):49-68. PubMed ID: 10459732
[TBL] [Abstract][Full Text] [Related]
20. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
